导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 67.78% | 112/2269 |
| 近一周 | 2.54% | 344/2338 |
| 近一月 | 3.20% | 313/2330 |
| 近一季 | 1.65% | 899/2324 |
| 近半年 | 48.28% | 209/2303 |
| 近一年 | 66.00% | 96/2260 |
| 近两年 | 76.32% | 116/2185 |
| 近三年 | 86.58% | 44/2063 |
| 成立以来 | 233.02% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
-1.02% 1871/2331 |
23.80% 16/2353 |
42.03% 265/2347 |
- - |
| 2024 | 5.71% 933/2336 |
-4.49% 1593/2322 |
-5.23% 1781/2326 |
8.49% 1087/2322 |
7.65% 172/2336 |
| 2023 | 5.19% 103/2330 |
6.24% 479/2290 |
-7.36% 1922/2303 |
-2.55% 821/2318 |
9.68% 8/2330 |
| 2022 | 0.66% 104/2299 |
10.10% 6/2227 |
-4.51% 2175/2269 |
-4.60% 719/2294 |
0.37% 760/2300 |
| 2021 | 12.69% 602/2205 |
5.74% 75/2009 |
6.23% 993/2060 |
-13.49% 1959/2103 |
15.97% 36/2208 |
| 2020 | 28.45% 1178/2086 |
-9.03% 1759/1861 |
21.92% 580/1950 |
-0.74% 1878/2010 |
16.69% 448/2031 |
| 2019 | 34.53% 759/1974 |
18.02% 1518/3053 |
-7.16% 2800/3201 |
8.50% 375/1861 |
13.16% 205/1886 |
| 2018 | - - |
- - |
- - |
1.10% 367/2970 |
-7.13% 1482/2975 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 易方达标普生物科技美元汇A | 0.2432 | 29.46% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 汇安行业龙头混合A | 2.4323 | 22.37% |
| 华商致远回报混合A | 1.6762 | 21.58% |
| 广发生物科技指数美元(QDII)C | 0.2047 | 18.46% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇 | 1.3424 | 17.84% |
| 华夏上证科创板半导体材料设备主题ETF联接C | 1.2373 | 17.83% |
| 宝盈国家安全沪港深股票C | 2.1469 | 17.42% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币A | 1.3726 | 17.14% |
| 广发上海金ETF | 9.7032 | 16.81% |
| 财通新视野灵活配置混合A VS. () |